ATM polymorphisms as risk factors for prostate cancer development.
Angèle S, Falconer A, Edwards SM, Dörk T, Bremer M, Moullan N, Chapot B, Muir K, Houlston R, Norman AR, Bullock S, Hope Q, Meitz J, Dearnaley D, Dowe A, Southgate C, Ardern-Jones A, Easton DF, Eeles RA, Hall J.
Angèle S, et al. Among authors: dearnaley d.
Br J Cancer. 2004 Aug 16;91(4):783-7. doi: 10.1038/sj.bjc.6602007.
Br J Cancer. 2004.
PMID: 15280931
Free PMC article.